Sigma Planning Corp’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $331K | Sell |
631
-158
| -20% | -$83K | 0.01% | 955 |
|
|
2025
Q1 | $500K | Buy |
789
+7
| +0.9% | +$4.44K | 0.02% | 737 |
|
|
2024
Q4 | $557K | Buy |
782
+373
| +91% | +$266K | 0.02% | 694 |
|
|
2024
Q3 | $430K | Buy |
409
+16
| +4% | +$16.8K | 0.01% | 797 |
|
|
2024
Q2 | $413K | Buy |
393
+25
| +7% | +$26.3K | 0.01% | 803 |
|
|
2024
Q1 | $354K | Buy |
+368
| New | +$354K | 0.01% | 884 |
|
|
2023
Q4 | – | Sell |
-385
| Closed | -$317K | – | 1099 |
|
|
2023
Q3 | $317K | Sell |
385
-70
| -15% | -$57.6K | 0.01% | 899 |
|
|
2023
Q2 | $327K | Sell |
455
-32
| -7% | -$23K | 0.01% | 903 |
|
|
2023
Q1 | $400K | Sell |
487
-148
| -23% | -$122K | 0.01% | 891 |
|
|
2022
Q4 | $458K | Buy |
635
+142
| +29% | +$102K | 0.02% | 791 |
|
|
2022
Q3 | $340K | Sell |
493
-53
| -10% | -$36.6K | 0.01% | 898 |
|
|
2022
Q2 | $323K | Sell |
546
-8
| -1% | -$4.73K | 0.01% | 952 |
|
|
2022
Q1 | $387K | Sell |
554
-96
| -15% | -$67.1K | 0.01% | 945 |
|
|
2021
Q4 | $410K | Buy |
650
+67
| +11% | +$42.3K | 0.01% | 919 |
|
|
2021
Q3 | $353K | Sell |
583
-753
| -56% | -$456K | 0.01% | 965 |
|
|
2021
Q2 | $746K | Sell |
1,336
-133
| -9% | -$74.3K | 0.02% | 650 |
|
|
2021
Q1 | $695K | Buy |
1,469
+274
| +23% | +$130K | 0.02% | 626 |
|
|
2020
Q4 | $577K | Sell |
1,195
-138
| -10% | -$66.6K | 0.02% | 633 |
|
|
2020
Q3 | $746K | Sell |
1,333
-3,689
| -73% | -$2.06M | 0.03% | 475 |
|
|
2020
Q2 | $3.13M | Buy |
5,022
+4,173
| +492% | +$2.6M | 0.14% | 160 |
|
|
2020
Q1 | $415K | Sell |
849
-525
| -38% | -$257K | 0.02% | 544 |
|
|
2019
Q4 | $516K | Buy |
1,374
+85
| +7% | +$31.9K | 0.02% | 581 |
|
|
2019
Q3 | $358K | Buy |
1,289
+254
| +25% | +$70.5K | 0.02% | 692 |
|
|
2019
Q2 | $324K | Buy |
+1,035
| New | +$324K | 0.02% | 695 |
|
|
2018
Q4 | – | Sell |
-781
| Closed | -$316K | – | 928 |
|
|
2018
Q3 | $316K | Sell |
781
-78
| -9% | -$31.6K | 0.02% | 653 |
|
|
2018
Q2 | $296K | Buy |
859
+265
| +45% | +$91.3K | 0.02% | 652 |
|
|
2018
Q1 | $205K | Buy |
+594
| New | +$205K | 0.02% | 766 |
|